Literature DB >> 1714653

Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan.

S Sidney1, C Quesenberry, M C Sadler, E G Lydick, H A Guess, E V Cattolica.   

Abstract

The relationship of age, medical history, personal habits, and urologic symptoms to the incidence of surgically treated benign prostatic hyperplasia (BPH) was studied in a cohort of 16,219 men, aged forty years and over, who received multiphasic health checkups (MHCs) during 1971 and 1972 in Oakland or San Francisco while members of the Northern California Kaiser Permanente Medical Care Program, a large prepaid health care program. Follow-up was carried out for surgically treated BPH from the date of the MHC to the date of the earliest of the following: surgery for BPH (n = 1,027); incidence of prostate cancer (n = 329), bladder cancer (n = 119), or both (n = 10); other prostate surgery (n = 5); death (n = 2,525); membership termination (n = 4,235); or December 31, 1987 (n = 7,969). The mean length of follow-up was twelve years. In multivariate analysis utilizing the Cox proportional hazards model, the following characteristics were positively associated (p less than 0.05) with risk of surgically treated BPH: age, low body mass index, nonsmoking (vs. current smoking), urine pH greater than 5, history of kidney x-ray and of tuberculosis, and each of five urologic symptoms (dysuria, loss of bladder control, trouble starting urination, nocturia, slow urine stream). The risk of BPH associated with obstructive urologic symptoms decreased markedly with age. Some of these findings are consistent with those from other studies (age, nonsmoking), while others (high urine pH, history of tuberculosis) are new and should be examined in other study populations.

Entities:  

Mesh:

Year:  1991        PMID: 1714653     DOI: 10.1016/0090-4295(91)80193-b

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

1.  Serum lipid levels in benign prostatic hyperplasia.

Authors:  Murat Lekili; Talha Müezzinoğlu; Bekir Sami Uyanik; Coşkun Büyüksu
Journal:  World J Urol       Date:  2006-02-28       Impact factor: 4.226

2.  Evaluating racial/ethnic disparities in lower urinary tract symptoms in men.

Authors:  Stephen K Van Den Eeden; Jun Shan; Steven J Jacobsen; David Aaronsen; Reina Haque; Virginia P Quinn; Charles P Quesenberry
Journal:  J Urol       Date:  2011-11-17       Impact factor: 7.450

3.  Reducing the risk of benign prostatic hyperplasia progression.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2002

Review 4.  Bladder dysfunction in patients with diabetes.

Authors:  Christopher S Gomez; Prashanth Kanagarajah; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 5.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

6.  Hyperglycemia, hyperinsulinemia, insulin resistance, and the risk of BPH/LUTS severity and progression over time in community dwelling black men: the Flint Men's Health Study.

Authors:  Lauren P Wallner; John M Hollingsworth; Rodney L Dunn; Catherine Kim; William H Herman; Aruna V Sarma
Journal:  Urology       Date:  2013-07-31       Impact factor: 2.649

7.  Smoking and acute urinary retention: the Olmsted County study of urinary symptoms and health status among men.

Authors:  Aruna V Sarma; Debra J Jacobson; Jennifer L St Sauver; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

8.  Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study.

Authors:  Seyung Kim; Jin Young Jeong; Yong Jun Choi; Dong Hyun Kim; Won Ki Lee; Seong Ho Lee; Sang Kon Lee
Journal:  Korean J Urol       Date:  2010-07-20

Review 9.  Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies.

Authors:  Huan Xu; Shi Fu; Yanbo Chen; Qi Chen; Meng Gu; Zhong Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP).

Authors:  Huan Xu; Chong Liu; Meng Gu; Yanbo Chen; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Oncotarget       Date:  2017-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.